Actimag

Quick links to important sections

Actimag

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Actimag

Property Description
Active Ingredient Magnesium Pidolate (INN)
Form Oral Solution (Solution buvable)
Pharmacological Class Magnesium Supplement, Electrolyte Replenisher (ATC: A12CC08)
Common Purpose Correcting or preventing Magnesium Deficiency (Hypomagnesemia)
Origin Synthetic organic magnesium salt

Actimag: Classification and General Purpose

Actimag is a non-prescription medicinal product whose core function is to serve as a Magnesium supplement and an Electrolyte replenisher. It is formally classified under the Anatomical Therapeutic Chemical (ATC) code A12CC08. The primary therapeutic purpose of the product is to address or prevent a documented deficiency of the essential mineral, magnesium, a condition often termed hypomagnesemia.

This single-ingredient agent is clinically recognized for its role in mineral replacement therapy. A common use scenario involves supporting individuals with signs indicating a magnesium deficit, which is crucial as the mineral participates in hundreds of biochemical processes vital for nerve and muscle function.


What is Magnesium Pidolate and Its Form?

The active compound in Actimag is Magnesium Pidolate (INN), a synthetic organic magnesium salt where the elemental magnesium is bound to pidolic acid. This preparation is typically supplied as an oral solution (solution buvable). This liquid form allows for flexible and convenient intake, targeting both adults and the paediatric population in many markets.

Pharmacological studies confirm that this specific organic salt structure is selected to enhance the mineral's systemic delivery. The formulation's primary aim is to maximize the absorption of the elemental magnesium component.


The Advantage of the Pidolate Form

The unique structure of the Magnesium Pidolate component is a key differentiating feature that supports enhanced bioavailability. The pidolate molecule acts as a carrier, facilitating the efficient transfer of the magnesium ion across intestinal barriers and into the cells where the mineral is most required. This delivery system promotes reliable cellular uptake, differentiating it from products utilizing less readily absorbed inorganic compounds, ultimately aiming for the sustained restoration of magnesium concentrations in the body's tissues.

What side effects are possible with Actimag?

The safety profile of Actimag (Magnesium Pidolate) is based on adverse reactions and safety constraints documented in governmental regulatory labeling. Common reactions are generally tied to dose, while the most serious concern is defined by the risk of magnesium excess in vulnerable populations.

Adverse Reaction Scope

Category Regulatory Documentation Note
Common Adverse Reactions Nausea, vomiting, and diarrhoea are the most frequently documented adverse events, typically associated with the gastrointestinal system.
Frequency Classification Adverse reactions are generally noted as occurring in some cases, and always related to high doses; standard frequency categories are not typically applied.
System-Organ Classes Involved Gastrointestinal disorders (e.g., diarrhoea) and Vascular disorders (e.g., hypotension) are listed as body systems affected by common reactions.

Serious Adverse Reactions and Safety Constraints

The most serious risk documented in official prescribing information is Hypermagnesemia (Magnesium intoxication), which is an excess of the mineral in the blood. The official label defines its serious manifestations, which can include the slowing of the heartbeat (bradycardia), respiratory depression, muscle weakness, and the potential for coma.

Population-Specific Safety Considerations

Individuals with impaired renal function (kidney failure) are explicitly noted in regulatory documents as being at a significantly higher risk of developing hypermagnesemia due to reduced mineral clearance. For this reason, Kidney failure and specific neurological conditions like Myasthenia Gravis are listed among the safety restrictions and limitations for use.

High-Level Safety Note

Official documents also include safety consequences related to concurrent use with other medications. The use of this medicine may, for example, inhibit the absorption of digitalis glycosides (heart medications) or reduce the absorption of certain HIV medications, a consequence defined within the regulatory text.

Overdose and Emergency Response

Overdose from Actimag (Magnesium Pidolate) is strictly defined by the officially documented signs of hypermagnesemia (excess magnesium), as presented in regulatory labeling. The clinical profile involves the progressive depression of the central nervous system (CNS) and neuromuscular function. Initial manifestations include drowsiness, confusion, flushing, sweating, and hypotension (a drop in blood pressure). A primary sign of escalating toxicity is the depression of deep tendon reflexes, with the disappearance of the patellar reflex noted as a key indicator.

Severe overdose scenarios involve life-threatening outcomes affecting critical systems. Documented outcomes include respiratory paralysis, cardiac depression, heart block, and eventual circulatory collapse. Regulatory guidance explicitly mandates that immediate medical attention must be sought if severe toxic manifestations occur, particularly any difficulty with breathing or signs of profound circulatory instability.

Special consideration for toxicity risk is noted for patients with renal impairment, as they face a significantly increased risk of hypermagnesemia due to the lack of magnesium excretion. The officially described emergency action for acute toxicity is the intravenous administration of an injectable calcium salt, such as calcium gluconate, which is documented as a physiological antagonist to counteract the acute toxic effects. Supportive measures, including hemodialysis for severe cases, are also outlined in regulatory documents.

Therapeutic Uses of Actimag

What Actimag Treats: Main Uses and Benefits

Actimag is primarily applied as a magnesium supplement to address documented magnesium deficiency (hypomagnesemia), which may arise from inadequate intake or increased physiological loss. Correction of this underlying mineral deficit is generally considered relevant for systemic stability, which generally supports systemic balance. This therapy is commonly used to help with the correction of the deficit itself. It is considered relevant in contexts where low magnesium levels contribute to the difficulty in stabilizing other electrolytes, such as refractory hypokalemia (low potassium) or hypocalcemia (low calcium).

The product is applied in addressing symptom clusters related to neuromuscular hyperexcitability. It is used to help address symptoms that create noticeable physiological strain, including muscle spasms, persistent cramps, muscular twitching (fasciculations), and generalized fatigue or weakness. Providing symptomatic relief is relevant when symptoms create noticeable physiological strain, which may help patients cope more steadily with these manifestations.

Actimag may also be part of symptomatic management for conditions characterized by episodic or fluctuating manifestations of pain. It is relevant for easing discomfort related to migraine headaches and tension-type headaches, as well as managing the symptomatic burden of primary dysmenorrhea (menstrual cramping). In these scenarios, it is commonly used when short-term symptomatic assistance is needed, providing support that assists with reducing the symptom burden that interferes with routine activities. The product is considered relevant for diverse patient groups, including adults and the pediatric population where appropriate, and for those with risk factors like gastrointestinal disorders or chronic use of certain diuretics.


Quick Fact: Relief for Muscle Spasms
Actimag is commonly used to help address the involuntary muscle spasms and cramps that often accompany magnesium deficiency, supporting a reduction in discomfort and helping to ease the symptom burden on daily activities.

Regulatory References

  1. NIH StatPearls overview of Magnesium

Eligibility and Restrictions for Use

Actimag (Magnesium Pidolate) is officially indicated for use in Adults to correct documented magnesium deficiency. Regulatory documents define specific populations who are strictly restricted or prohibited from using the product.

Populations Who Must Not Use Actimag (Contraindications)

Use is strictly contraindicated for patients with Kidney failure, Myasthenia Gravis, Diabetic coma, or Cushing's disease. Contraindication also applies to individuals with a known hypersensitivity to the active substance or excipients.

Official labeling prohibits use in patients with certain gastrointestinal conditions, including Chronic diarrhoea, Ileostomy, Ulcerative colitis, and when Symptoms of appendicitis are present. Furthermore, patients with hereditary metabolic disorders such as fructose intolerance must not use the oral solution due to its excipient content.

Use Limitations and Restrictions

Actimag is not recommended for children less than 12 years old, as its safety and efficacy have not yet been established by regulators in this age group. Use requires caution in older adults and patients with impaired renal function (when not severe) and in those with calcium metabolism disorders. Official labeling states that use is generally permitted during pregnancy and lactation.

What should I know about interactions with other medicines?

Actimag, which contains magnesium, may interact with several other medicines and supplements, primarily by reducing their absorption in the digestive tract. It is essential to consult a healthcare provider before starting or stopping any medication when taking Actimag.

Type of Interacting Agent Effect of Interaction Recommendation
Certain Antibiotics (e.g., Tetracyclines, Fluoroquinolones) Magnesium can bind to the antibiotic, significantly reducing its absorption and effectiveness. Separate the administration of Actimag and the antibiotic by at least 2 to 4 hours.
Bisphosphonates (for osteoporosis, e.g., alendronate) Magnesium may reduce the absorption and effectiveness of bisphosphonates. Take Actimag at least 2 hours before or after the bisphosphonate medication.
Thyroid Hormones (e.g., Levothyroxine) Actimag may decrease the absorption of thyroid hormones. Separate the dose of Actimag and the thyroid medication by several hours as directed by a physician.
Other Agents Digitalis glycosides, penicillamine, and certain antiviral medications may have reduced absorption. Discuss with your doctor for specific dosing instructions.
Calcium Salts Simultaneous use of high doses of calcium and magnesium can competitively inhibit the absorption of both minerals. Avoid taking high-dose calcium supplements at the same time as Actimag.

Simultaneous use of Actimag with diuretics or long-term use of Proton Pump Inhibitors (PPIs) may also affect magnesium balance, requiring careful monitoring by a healthcare professional.

Mechanism of Action

Actimag's mechanism is defined by the essential biological role of the magnesium ion ( Mg^2+), efficiently delivered by the Pidolate carrier to support fundamental biological processes. The Mg^2+ ion engages simultaneous, fundamental mechanisms across multiple regulatory systems.

Cofactor Role in Energy and Enzyme Homeostasis

The mechanism requires Mg^2+ as an obligatory cofactor for over 300 enzyme systems, including those that manage ATP (cellular energy) utilization. Supporting the Mg^2+ requirement for enzymes like the Na^+/ K^+- ATPase pump aids the structural integrity and electrical potential required for cellular function.

Antagonism of Ca^2+ and Receptor Modulation

This core mechanism involves Mg^2+ acting as a physiological antagonist to Ca^2+ (calcium). It competes for binding sites on voltage-gated Ca^2+ channels and non-competitively blocks the NMDA receptor in the CNS. This action directly lowers the threshold for nerve and muscle fiber activation, influencing the state of electrical signaling.

Modulation of Smooth Muscle and Vascular Tone

The final mechanistic domain involves the effect of restored Mg^2+ concentrations on involuntary muscle. By limiting excessive Ca^2+ influx into smooth muscle cells, Mg^2+ reduces Ca^2+-dependent contraction. This leads to relaxation of tissues such as the smooth muscle in the vasculature, thereby influencing peripheral vascular resistance.

Dosage and Administration Information

How to Use Actimag: Standard Administration Guidelines

Actimag is formulated as a Magnesium Pidolate oral solution and is administered exclusively via the oral route.

Administration is generally recommended to occur with food intake. This contextual instruction is provided to mitigate the potential for gastric discomfort or diarrhea, thereby supporting proper administration and patient adherence. The prescribed dosing is structured based on age, while allowing for clinical flexibility in severe deficiency states.


Dosing and Frequency Schedule

The standard administration volume is 5 mL of the oral solution per dose.

Population Group Standard Daily Dosing Pattern Special Condition
Adults 5 mL twice a day (BD) The dose may be increased on medical criteria for major magnesium deficits.
Paediatric Population 5 mL once a day (OD) Administration must be accompanied by a medical prescription.

Usage Constraints

The treatment duration is not fixed but is intended to be part of a supervised course; continuous use without medical oversight is not specified. Furthermore, for patients with reduced kidney function (including older adults), the frequency and volume of administration must be adjusted by a healthcare professional according to the degree of renal impairment. These procedural rules establish a standardized protocol for administering the product based on the patient’s age and clinical status.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Actimag

The research for magnesium supplementation, including formulations like Actimag (Magnesium Pidolate), involves various study types, such as Randomized Controlled Trials (RCTs), comparative controlled trials, and large-scale systematic reviews that pool data from multiple studies. These investigations primarily monitor patient-reported outcomes describing perceived discomfort or measure changes in key blood markers to understand the role of magnesium.


Evidence for Use in Correcting Magnesium Deficiency (Hypomagnesemia)

Studies have been conducted during periods of temporary physiological imbalance, focusing on individuals with documented low serum magnesium concentration (hypomagnesemia). The research involves controlled trials that examine the elemental magnesium component's absorption and the measurement of changes in mineral levels. Some trials have included a comparison of Magnesium Pidolate against other magnesium salt formulations to study their absorption and reported measurements of biomarker normalization.

Findings describe patterns observed in the studies, with research documenting measured shifts in serum magnesium levels following administration of the supplement. Studies report how the elemental magnesium component was observed in protocols intended for the prevention and correction of the biochemical deficit (hypomagnesemia). However, long-term effects are not fully established regarding the sustained maintenance of optimal magnesium balance over many years.


Evidence for Use in Primary Dysmenorrhea (Menstrual Cramps)

Research has explored the use of magnesium supplementation in conditions characterized by fluctuating or episodic manifestations of pain, specifically in women experiencing painful periods (primary dysmenorrhea). The main outcomes monitored included changes in the intensity of cramping pain and the overall burden of symptoms across several menstrual cycles.

Findings across different trials and meta-analyses are heterogeneous, with some studies reporting differences in measured outcomes while others described minimal or no difference compared to placebo. The evidence quality varies across studies, and findings were mixed, indicating that research exploring consistent outcomes across all patient populations is needed.

Key Studies & References

  1. Magnesium. StatPearls [Internet].
  2. Hypomagnesemia

Frequently Asked Questions (FAQ)

Common questions about Actimag (FAQ)


Q: Is it normal to feel a bit drowsy or dizzy after starting Actimag?

Official product information notes that feeling dizzy or drowsy (somnolence) can be a potential sign of magnesium excess, especially in overdose. Additionally, low blood pressure (hypotension) is listed as an occasional side effect. This information is provided for discussion with a healthcare professional.

Q: What happens if I forget to take my dose of Actimag?

If a dose is missed, general guidance suggests taking it as soon as it is remembered. However, general guidance suggests avoiding taking a double dose to compensate for a missed dose.

Q: Is it safe to drive or operate machinery while taking Actimag?

Official patient information generally includes a warning if a medicine could affect the ability to drive or use machinery. Since Actimag has the potential to cause side effects such as dizziness and low blood pressure (hypotension), caution is advised if operating equipment or driving.

Q: What happens if I take more Actimag than the recommended amount?

Taking more than the prescribed amount can lead to hypermagnesemia, or magnesium excess. This condition is characterized by symptoms such as nausea, vomiting, drowsiness, muscle weakness, and a slowing of the heartbeat (bradycardia). If an overdose is suspected, it is critical to seek emergency medical attention.

Q: Does Actimag need to be taken at a specific time relative to other medication?

Yes, regulatory documents indicate that Actimag must be separated from certain other medications by a specific time interval. For example, to ensure proper absorption, Actimag must be taken at least 2 to 4 hours apart from medications such as antibiotics, bisphosphonates (for bones), and thyroid hormones.

Q: What should I do if a side effect from Actimag feels bothersome but not severe?

Official guidance suggests that if an adverse effect occurs, such as common gastrointestinal issues, the treatment may need to be stopped if the effects are bothersome. Any adverse effects should be discussed with a healthcare professional or reported through the appropriate channels.

Q: Can taking Actimag make other medicines I'm on work better or worse?

Regulatory documents confirm that Actimag is known to interact with other medicines by potentially reducing their absorption in the body, which can make them work less effectively. This interaction specifically involves several types of drugs, including certain antibiotics, bisphosphonates, and digitalis glycosides (heart medications).

Q: Are there specific symptoms that mean Actimag might not be agreeing with me?

It is important to know the potential signs of serious magnesium excess (hypermagnesemia). These symptoms, which clearly indicate the medicine may not be agreeing with the body, include severe muscle weakness, extreme drowsiness, respiratory depression, and a significant slowing of the heartbeat.

Q: What should I look out for that indicates a serious allergic reaction to Actimag?

Official product information warns against using the medicine if a person has a known hypersensitivity to the ingredients. Signs of a serious allergic reaction may include facial swelling, difficulty breathing, a rash, or severe dizziness.

Q: Is it safe to take Actimag if I have diabetes?

Use of Actimag is strictly prohibited (contraindicated) for patients with a history of diabetic coma. Additionally, the oral solution formulation contains sucrose (sugar), which is a necessary consideration for individuals managing diabetes.

Q: Are there dietary restrictions that go along with taking Actimag?

Yes, regulatory documents advise that simultaneous use of high doses of calcium salts can competitively inhibit the absorption of both minerals. For this reason, concurrent use of high-dose calcium supplements is often advised against.

Q: Does Actimag affect blood pressure or heart rate?

Official information indicates Actimag can affect both. Low blood pressure (hypotension) is listed as an occasional adverse reaction. Furthermore, a severe excess of the medicine can cause a serious manifestation involving the slowing of the heartbeat (bradycardia).

Q: Can Actimag cause changes in mood or anxiety levels?

While regulatory documents do not directly list mood or anxiety changes, severe overdose is known to cause depression of the central nervous system. This condition involves symptoms like fatigue and somnolence (drowsiness).

Q: Is Actimag the same thing as other magnesium supplements I see at the store?

No, Actimag is formulated as Magnesium Pidolate, which is a specific synthetic organic salt. Regulatory studies indicate this particular form is selected because the Pidolate carrier enhances the absorption and bioavailability of the elemental magnesium component compared to many other compounds available over-the-counter.

Q: Can Actimag be crushed or split if it's hard to swallow?

Actimag is a liquid product specifically formulated as an oral solution. It is administered exclusively by the oral route and is not available in a tablet or capsule form that would require crushing or splitting.

Q: How long does Actimag stay in your system after you stop taking it?

Magnesium is an essential mineral primarily eliminated from the body by the kidneys. In individuals with normal kidney function, the regulatory documents indicate that over 90% of the active ion is typically eliminated within 24 hours of administration.

Q: Is Actimag generally well-tolerated by most people who use it?

The safety profile indicates that the most common adverse reactions are typically mild and limited to the gastrointestinal system, such as nausea or diarrhea. These effects are generally associated with higher doses of the medication.

Q: Why is Actimag sometimes recommended for muscle cramps or spasms?

Actimag's mechanism of action involves the magnesium ion acting as an antagonist to calcium. This action influences nerve and muscle fiber activation and reduces calcium-dependent contraction in smooth muscle, leading to tissue relaxation, which can address cramps and spasms.

Q: Is the research on Actimag still ongoing, or is it a well-established drug?

The research is established for correcting magnesium deficiency, but studies for other uses, such as for painful periods (primary dysmenorrhea), have shown mixed results. The official research overview indicates that studies exploring consistent outcomes across all patient populations are still needed.

Q: If I have trouble sleeping, is it better to take Actimag in the morning or at night?

The standard adult dosing is specified as twice a day (BD). However, the official documents do not specify whether the timing should be morning/night or provide advice on optimal timing related to sleep or insomnia.

How should Actimag be stored and disposed of?

Actimag (Magnesium Pidolate Oral Solution) must be stored and disposed of according to specific instructions to maintain its quality and ensure safety.

Official Storage Requirements

Condition Requirement
Temperature Store below the maximum allowed temperature, typically room temperature, and do not freeze the solution.
Protection Keep the medicine in its original container and ensure the bottle is tightly closed to protect it from light and moisture.
Stability Adhere to any specified post-opening limits for use (e.g., discard after a certain number of days) to ensure the stability of the multi-dose liquid.
Safety The medicine must be kept out of the sight and reach of children.

Disposal Instructions

Expired or unused Actimag must not be disposed of in household waste or flushed down the toilet. The product should be discarded in accordance with local regulations, which typically involves returning it to a pharmacy or using designated collection programs for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Actimag found in:

A-Z Index: